Perrigo Plc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Perrigo Plc's ROA in the third quarter of 2026?
Perrigo Company Plc had a negative return on assets (ROA) of -19.78%, due to the net loss of $-1 billion, during the twelve months ending in the third quarter of 2026.

However, within the Healthcare sector 359 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 26 2026 quarter, so far to 3459, from total ROA ranking in the second quarter of 2026 at 3931.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Total Assets Change	-3.44 %	-20.13 %	-18.08 %	34.96 %	26.28 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-1,757	-1,722	-1,805	-1,413	-52
Return On Assets (TTM)	-19.78 %	-19.21 %	-18.87 %	-14.12 %	-0.55 %
PRGO's Total Ranking	# 3459	# 3931	# 2653	# 2712	# 2831
Total Assets (TTM) in million	9,468	9,541	7,983	8,535	9,806
Seq. Total Assets Change	-0.76 %	19.51 %	-6.47 %	-12.96 %	-17.92 %
Seq. Net Income Change	-	-	-	-	-

PRGO's 5 Years Annual ROA >> Back to PRGO Management Effectiveness >> Compare PRGO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 130
Sector	# 360
Overall	# 3436

Return On Assets Statistics
High	Average	Low
2.51 %	-3.04 %	-23.76 %
		(Dec 31 2016)

Financial Statements
Perrigo Plc's Assets	$ 9,468 million	PRGO's Balance sheet
Perrigo Plc's Income	$ -28 million	Quarterly PRGO's Income Statement
PRGO's Income by Division		See PRGO's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	34.96 %	-13.09 %	-2.57 %	0.64 %	-41.84 %
Total Assets in million	8,535	6,324	7,277	7,469	7,422
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-1,425	-172	-13	-2	190
Annual Return On Assets	-16.7 %	-2.72 %	-0.17 %	-0.02 %	2.56 %

PRGO's 5 Years Annual ROA >> Back to PRGO Management Effectiveness >> Compare PRGO ROA to its Competitors

More Return On Assets Ratios
PRGO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRGO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRGO's Competitors
Subscribers only: Roa for Perrigo Plc's Suppliers
Subscribers only: Return On Assets for PRGO's Customers

You may also want to know
PRGO's Roi	PRGO's Inventory Turnover Ratio	PRGO's Growth Rates	PRGO's Dividend Comparisons
	PRGO's Profitability Ratios	PRGO's Asset Turnover Ratio	PRGO's Dividend Growth
PRGO's Roe	PRGO's Valuation Ratios	PRGO's Financial Strength Ratios	PRGO's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 26 2026, within Healthcare Sector

ROA

Date modified: 2026-11-06T13:00:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.